EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3

Zhisheng Jie, Kadeer Tudi, Zihao Chen, Jiawen Huang iD, Ganghua Tang iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.6c00356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Zhisheng Jie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Eva…. Hauptthemen laut MEDLINE: Glypicans, Fluorine Radioisotopes, Radiopharmaceuticals, Fluorides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To develop an effective GPC3-targeted PET probe for tumor imaging, [18F]AlF-NOTA-A2P-GPC3P was synthesized by introducing the hydrophilic linker A2P into the L5 peptide scaffold. The probe was efficiently radiolabeled using the [18F]AlF method, exhibiting high hydrophilicity (Log D = -3.11 ± 0.31) and excellent in vitro and in vivo stability. Cellular uptake assays verified that the probe was significantly more highly taken up by GPC3-positive cell lines than by GPC3-low cell lines, confirming its specific binding to GPC3-positive cells. Micro-PET/CT and biodistribution studies in GPC3-positive tumor models (ASPC1, A549-GPC3) demonstrated specific uptake, significantly improved tumor-to-background ratios (especially tumor-to-lung and tumor-to-heart ratios), and reduced hepatic accumulation compared with the reported probe. Blocking studies in GPC3-positive tumors (ASPC1) confirmed its specificity. Thus, [18F]AlF-NOTA-A2P-GPC3P is a promising PET imaging agent for GPC3-positive tumor detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlypicansFluorine RadioisotopesRadiopharmaceuticalsFluoridesAnimalsHumansTissue DistributionMicePositron Emission Tomography Computed TomographyCell Line, TumorMice, NudeHeterocyclic CompoundsPositron-Emission Tomography

Stichwörter der Autor:innen

PET imagingfluorine-18glypican-3hepatocellular carcinoma

Substanzen

GlypicansFluorine RadioisotopesGPC3 protein, humanRadiopharmaceuticalsFluoridesFluorine-18Heterocyclic Compounds

Autor:innen und Institutionen

  • Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfa…
  • School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong Province 510515, China.

ORCID-Profile: Jiawen Huang, Ganghua Tang

Förderung

  • National Key Research and Development Program of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Southern Medical University
  • Department of Education of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • National Natural Science Foundation of China
  • Guangdong Medical Products Administration

Zitieren

APA

Jie, Z., Tudi, K., Chen, Z., Huang, J., & Tang, G. (2026). Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00356

Vancouver

Jie Z, Tudi K, Chen Z, Huang J, Tang G. Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00356

BibTeX
@article{Jie2026,
  author = {Jie, Zhisheng and Tudi, Kadeer and Chen, Zihao and Huang, Jiawen and Tang, Ganghua},
  title = {Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.6c00356}
}
Kostenlos starten →